title: Galectin-3: A potential new target for upstream therapy of atrial fibrillation.
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China; Cardiovascular Research Institute of Wuhan University, PR China.
authors.forename: Bo
authors.initials: B
authors.lastname: He
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China; Cardiovascular Research Institute of Wuhan University, PR China.
authors.forename: Bing
authors.initials: B
authors.lastname: Huang
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China; Cardiovascular Research Institute of Wuhan University, PR China.
authors.forename: Zhibing
authors.initials: Z
authors.lastname: Lu
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China; Cardiovascular Research Institute of Wuhan University, PR China.
authors.forename: Wenbo
authors.initials: W
authors.lastname: He
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China; Cardiovascular Research Institute of Wuhan University, PR China. Electronic address: hong-jiang@whu.edu.cn.
authors.forename: Hong
authors.initials: H
authors.lastname: Jiang
mesh_terms: D001281:Atrial Fibrillation / Q000097:blood* / Q000628:therapy; D064752:Atrial Remodeling; D015415:Biomarkers / Q000097:blood; D005355:Fibrosis / Q000378:metabolism / Q000473:pathology; D037502:Galectin 3 / Q000097:blood*; D006801:Humans; D011237:Predictive Value of Tests
chemical_list: D015415:Biomarkers; D037502:Galectin 3
keywords: Atrial fibrillation; Fibrosis; Galectin-3